Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
100 Cards in this Set
- Front
- Back
Structural nonspecific drugs act in what way? and 1 ex
|
physical ways
antacids |
|
Structurally specific acting agents act how?
|
with a specific receptor that initiates a specific biologic response or transduction of a signal
|
|
Structurally specific acting agents are also called...
|
ligands
|
|
Receptors are usually located where? and composed of what? and are usually ____ for a certain ligand
|
in/on a membrane
protein stereospecific |
|
Which affinity is higher 1mcg or 1mg? and why
|
1mcg, b/c takes only 1mcg to saturate receptor
|
|
Potency?
|
min amt. reqd to elicit response
|
|
Efficacy?
|
can we get a full response when ligand interacts w/ receptor
|
|
A receptor is usually composed of _____ AA's
|
3-4
|
|
A biologic response is the result of...
|
interaxn of drug w/ fxnal group of molecules
|
|
____ forces must be involved in the drug-receptor complex
|
weak forces
|
|
Drug must have ____ to interact well w/ receptor
|
high degree of structural specificity w/ complimentary groups
|
|
Bonds used by ligands to interact w/ receptor (6) (and which is not weak?)
|
1)hydrogen bonds
2)ionic bonds 3)van der waals 4)hydrophobic 5)dipole-dipole 6)covalent**** |
|
3 types of ionic bonds (and what makes them ionic bonds)
|
1)ionic
2)ion-dipole 3)reinforced ionic interaxns require a charge |
|
What groups can form Hydrogen bonds (4) and why?
|
-OH, -COOH, -NH2, =NH
b/c of excessive electrons on O and N |
|
___ bonds are seen in suicide interaxns
|
covalent
|
|
4 major types of steric factors influence pharmacological activity?
|
2)geometric isomerism
1)optical isomerism 2)conformational isomerism 3)isosterism |
|
Constitutional isomer? (2)
|
1)difference in connectivity
2)different physical properties |
|
Configurational isomer (3)
|
1)differing in the spatial array of atoms
2)non-superimposable 3)usually contain a chiral carbon |
|
Conformational isomer? (2)
|
1)differing in spatial array of atoms in a molecule of a given constitution and configuration
2)rotamers |
|
What determines which rotamer a receptor will accept?
|
will accept one that is most stable w/ least amount of energy
|
|
Enantiomers? (2)
|
1)non-superimposable
2)mirror images |
|
Difference in biologic activity b/w optical isomers depends on....
|
ability to react selectively at an asymmetric center in the biological system
|
|
4 things to overcome before desired biologic response
|
2)membrane selectivity
3)selective metabolism 4)non-specific receptors 5)desired response |
|
Ligand activity can be lost via...
|
acting @ non-specific receptors
|
|
Why do enantiomers differ in biologic response (4)
|
1)difference in reactivity at the receptor site
2)selective metabolism of one isomer 3)selective adsorption by membranes 4)rxns at non-specific receptors, thus loss of activity |
|
If asked on test which isomer has the majority of activity + or - which is usually right?
|
-
|
|
Problem with chiral compounds? and what must be done to drugs w/ chiral carbons?
|
having more than 1 chiral carbon gives many isomers
the different isomers must be separated (chiral separation) |
|
B2 adrenergic receptor has how many domains and what are domains?
|
7 domains
[]ed areas of AAs in membrane |
|
What 3 AAs form AS of B2 adrenergic receptor and use what kind of bonds?
|
Serine 204, Serine 207, Aspartate 113
2 hydrogen bonds, 1 ionic bond |
|
Geometric isomer types (2)
|
1)diasteriomers
2)cis/trans isomers |
|
Influence of geometric isomerism on pharmacological activity
|
differences in interatomic distances of groups influences pharmacological activity at receptor
|
|
Conformational isomerism and pharmacological activity (3)
|
1)have non-identical spatial arrangement b/c of rotation of atoms about a single bond
2)difficult to predict which conformation interacts w/ receptor best 3)pharmacophore that binds to the receptor maybe different than the preferred conformation in the crystalline state |
|
Stay away from what when making a drug?
|
drugs w/ a rotatable bond b/c it results in too many CONFORMATIONS
|
|
Pharmacophore building from ___ is done....
|
knowledge of the structure of the target (receptor)
|
|
Will any compound with proper dimensions to have activity at an opoid receptor always be an opoid?
|
NO
|
|
Drug of know pharmacological profile is ID'd as the....
|
lead compound
|
|
Analogs of the lead compound are synthesized by....(2)
|
1)modify structure to retain/reinforce the desirable effect while minimizing unwanted effects
2)use target analogs as pharmacological probes |
|
Molecular modifications of the "lead compound" can involve one or more of the follow strategies:(5)
|
1)bioisosteric replacement
2)design of rigid analogs 3)homologation of alkyl chains 4)alteration of stereochemistry 5)alteration of interatomic distances |
|
Bioisosterism
a)derived from... b)bioisosteric similarity of molecules is commonly assigned on basis of.... c)2 subdivision of bioisosterism |
a)certain physical properties of chemically different substances are similar
b)valence of electrons of an atom c)classical bioisosteres, nonclassical bioisosteres |
|
Most common classical bioisosteres (2)
|
1)F for H
2)OH for NH |
|
What happens to acid in the stomach via stimulated by...
a)PSNS b)SNS |
a)increase in acid
b)decrease in acid |
|
Parietal Cell fxn and mechanism (2)
|
1)puts acid into stomach using an H/K pump
2)does this when H2 histamine receptor is stimulated |
|
ECL Cell fxn and mechanism (3)
|
1)secretes histamine to activate parietal cell @ H2 receptor
2)is activated by neurocrine via ACh receptor 3)OR is activated by endocrine via Gastrin receptor |
|
Decrease acid to the stomach via 2 mechanisms (2)
|
1)inhibit H/K pump
2)block histamine H2 receptor |
|
____ goes from kidney to bladder
|
ureters
|
|
Urogenital system is controlled by...(2)
|
1)smooth muscle
2)ANS |
|
Urinary bladder parts (4)
|
1)detrusor (which contracts to squeeze urine out of bladder)
2)trigone (sphincter muscle that allows urine out of bladder) 3)ureter (how urine gets in) 4)urethra (how urine gets out) |
|
Urinary bladder smooth muscle activations (2)
|
1)M3 receptor activation causes contraction of detrusor and relaxation of trigone = micturation
2)B2 activation causes relaxation of detrusor and alpha1 activation causes contraction of trigone = retention |
|
How is bladder sort of controlled voluntarily?
|
Somatic muscles surround trigone and urethera to provide voluntary retention
|
|
When happens to penis when stimulated by...
a)SNS b)PSNS |
a)ejaculation
b)erection |
|
Penis parts fxns
a)seminal vesicle b)vas deferens c)prostatic capsule |
a)contains sperm
b)conveys sperm from testicles to seminal vesicle c)pushes semen out |
|
Penis activations (2)
|
1)alpha1 activation causes contraction of seminal vesicles, prosstatic capsule, vas deferens causing ejaculation
2)M3 receptor activation causes erection |
|
Which ANS mostly innervates vasculature (and exception)
|
SNS (except in penis)
|
|
Vascular smooth muscles activations (2)
|
1)alpha1/2 vasoconstriction
2)B2 vasodilation |
|
What receptor domainates
a)blood vessels to liver and skeletal muscle b)other blood vessels |
a)B2
b)alpha1 |
|
M3 is found rarely on BLOOD VESSELS, what is its effect?
|
VASODILATION
|
|
Vasodilation process in blood vessel at M3 receptor (2)
|
1)arginine to NO via NO synthase
2)NO and GTP to cGMP via guanyl cyclase |
|
Why will heart beat if pulled from chest?
|
b/c SA node spontaneously depolarizes
|
|
Receptor types found in heart and what dominates (2)
|
M2****
B1 |
|
Heart term definitions
a)inotropic b)chronotropic c)dromotropic |
a)contractile force
b)frequency of heart beat c)conduction thru AV node |
|
Heart activation of M2 receptor results (3)
|
1)decreased frequency of beating (negative chronotropic)
2)decrease in contractile force (negative inotropic) 3)delays conduction thru AV node (negative dromotropic) |
|
Heart activation of B1 receptor results (3)
|
1)increased frequency of beating (positive chronotropic)
2)increase in contractile force (positive inotropic) 3)enhances conduction thru AV node (positive dromotropic) |
|
____ not nerves line the inside of the heart
|
conducting fibers
|
|
M3 stimulates what secretory glands? (3) via what NT?
|
1)salivary
2)nasopharyngeal 3)sweat glands ACh |
|
alpha1 stimulates what secretion?
|
1)sparse amounts of think fluid from salivary gland
|
|
B2 receptor stimulates what secretion? (2)
|
1)amylase
2)insulin |
|
alpha2 receptor stimulates what secretion?
|
inhibits insulin release
|
|
Adenylate cyclase
a)activated by...(2) b)mechanism (4) |
a)adrenaline, glucagon
b1)adenylate cyclase gets activated @ B3 receptor b2)converts ATP to cAMP b3)cAMP activates PKA b4)PKA activates lipase |
|
Adipose tissue
a)receptor b)fxn |
a)B3
b)mediates lipolysis |
|
Glycogenolysis
a)receptor b)fxn c)most evident where? |
a)B2
b)convert glycogen to glucose in all tissues c)skeletal muscle, liver |
|
ACh effect on BP
|
decrease
|
|
Atropine is a....
|
muscarinic antagonist
|
|
LARGE ACh dose after atropine effect on BP
|
reduction in BP followed by increase in BP; overshoot caused by SNS overcompensation
|
|
Epinephrine after atropine effect on BP
|
increase in BP
|
|
phenoxybenzamine fxn
|
block alpha receptors irreversible
|
|
Epinephrine after atropine and phenoxybenzamine BP/HR effects
|
incr heart rate
decr BP (get B effects b/c alpha is blocked) (EPINEPHRINE REVERSAL) |
|
Cholinomimetic drugs (5)
|
1)methacholine
2)bethanechol 3)pilocarpine 4)nicotine 5)TMA |
|
Methacholine
a)metabolism (2) b)site of axn c)therapeutic use (2) |
a)not metabolized by pseudo cholinesterase; slowly metabolized by acetylcholinesterase
b)muscarinic agonist c)diagnostic for bronchial asthma, peripheral vascular spasms |
|
Bethanechol
a)metabolism b)site of axn c)therapeutic uses (2) |
a)NOT susceptible to hydrolysis by acetylcholinesterase
b)muscarinic receptors in GI and urinary bladder c)treat postoperative abdominal distension and postoperative urinary retention |
|
Pilocarpine
a)properties (3) b)site of axn c)therapeutic uses |
a)alkaloid, non-choline ester, tertiary amine
b)muscarinic receptors that can affect CNS by crossing BBB c)glaucoma |
|
Why is ACh not used clinically? (2)
|
1)massive metabolism
2)acts @ many sites in body |
|
Adverse effects of cholinomimetics? (6)
|
1)salivation
2)diaphoresis (incr sweating) 3)intestinal cramping 4)hypotension 5)dyspnea (via bronchoconstriction) 6)spasm of accommodation |
|
Adverse effects of cholinomimetics: Hypotension can be caused at 2 sites...
|
endothelial cell @ M3
SA node |
|
Narrow/closed angle glaucoma?
a)cause b)can cause... c)optical treatment |
a)blockage of drainage of aqueous humor (aqeous humor production is normal)
b)blindness due to pressure on optic nerve c)remove iris |
|
Open angle glaucoma cause
|
increased production of aqueous humor; drainage of it is normal
|
|
Mechanism of pilocarpine's treatment of glaucoma? and what type of glaucoma
|
cause miosis to facilitate drainage in narrow angle glaucoma
|
|
3 contraindications of cholinomimetics
|
1)bronchial asthma
2)gastrointestinal ulcer 3)hyperthyroidism |
|
Why are GI ulcer and hyperthyroidism contraindications of cholinomimetics?
|
1)cholinomimetics incr acid and incr GI smooth muscle contractions
2)mimetics are bad w/ hyperthyroidism b/c these ppl have sensitive myocardiums |
|
Direct acting nicotinic cholinomimetics fxn?
|
smoking cessation
|
|
Reversible cholinesterase inhibitors? (2)
|
1)physostigmine
2)neostigmine |
|
Reversible inhibitors of acetylcholinesterase act by...
|
inhibiting destruction of ACh
|
|
Physostigmine
a)mechanism b)sites of axn c)use d)unique feature e)drug category |
a)slowly hydrolyzed substrate for AChesterase; so ties it up
b)all cholinergic synapses c)miotic/glaucoma d)can cross BBB b/c not a quaternary ammonium salt (CNS axns) e)reversible inhibitors of ACHesterase |
|
Neostigmine
a)mechanism b)sites of axn c)use d)difference from physostigmine e)drug category |
a)slowly hydrolyzed substrate of AChesterase; so ties it up
b)indirect at all cholinergic synapses; direct @ neuromuscular jxn (somatic) c)myasthenia gravis (muscle weakness) via facilitating nerve impulses d)is a quaternary ammonium salt so NO CNS actions e)reversible inhibitor of ACHesterase |
|
Edrophonium
a)category of drug b)use c)axns are... |
a)reversible ACHesterase inhibitor
b)diagnosis of myasthenia gravis c)indirect, short |
|
General formula of IRReversible inhibitors of ACHesterase
|
O
|| R-P-X || R |
|
IRReversible inhibitors of ACHesterase act by...and are...
|
covalently phosphorylating esteratic site of cholinesterase
TOXIC |
|
IRReversible inhibitors of ACHesterase (2 and other are..)
|
1)DFP
2)Echothiophate 3)nerve gases, pesticides |
|
DFP
a)sites of axn b)therapeutic uses c)drug class d)warning e)CNS activity? |
a)all cholinergic synapses (indirect only)
b)miotic/glaucoma c)IRReversible inhibitors of ACHesterase d)crosses skin easily and is toxic if it does e)Yes |
|
Echothiophate
a)sites of axn b)therapeutic uses c)drug class d)CNS activity? |
a)all PERIPHERAL
b)miotic for narrow glaucoma c)IRReversible ACHesterase inhibitor d)NO |
|
Adverse effects of IRReversible ACHesterase inhibitors (4)
|
1)cholinergic overstimulation with paralysis of respiratory muscles
2)ganglionic blockade 3)cataracts 4)chronic neurotoxicity: weak leg, recovery slow |